Nasopharyngeal Microbiota as an early severity biomarker in COVID-19 hospitalised patients: a retrospective cohort study in a Mediterranean area Ines Escarra2023-02-06T08:41:43+00:00January 3rd, 2022|Categories: 2021, Health, News, Publications|Tags: Andreu Paytuví-Gallart, consulting, Covid| Read More
Investigation of Nasal/Oropharyngeal Microbial Community of COVID-19 Patients by 16S rDNA Sequencing Ines Escarra2023-02-06T08:57:52+00:00September 28th, 2021|Categories: Citations, Health|Tags: Covid, GAIA| Read More
Sequentia collaborated with Nextbiomics to obtain a novel immunization model against COVID-19 Ines Escarra2021-05-12T14:03:33+00:00May 12th, 2021|Categories: Health, News|Tags: Covid, Genomics, Microbiome| Read More
Phytotherapics in COVID19: Why palmitoylethanolamide? Ines Escarra2023-02-06T09:18:00+00:00December 11th, 2020|Categories: 2020, Health, News, Publications|Tags: Covid, Walter Sanseverino| Read More
The potential of cannabidiol in the COVID‐19 pandemic Ines Escarra2023-02-06T09:18:57+00:00November 10th, 2020|Categories: 2020, Health, News, Publications|Tags: Covid, Walter Sanseverino| Read More
Can the enteric nervous system be an alternative entrance door in SARS-CoV2 neuroinvasion? Ines Escarra2023-02-06T09:26:09+00:00October 2nd, 2020|Categories: 2020, News, Publications|Tags: Covid, Walter Sanseverino| Read More
Sequentia supports R&D to face COVID-19 Ines Escarra2021-04-23T15:38:23+00:00May 20th, 2020|Categories: Health, News|Tags: Covid, GAIA, metagenomics| Read More